{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:54:10Z","timestamp":1789325650441,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>As the society is aging, the increasing prevalence of osteoporosis has generated huge social and economic impact, while the drug therapy for osteoporosis is limited due to multiple targets involved in this disease. Zhuangguguanjie formulation (ZG) is extensively used in the clinical treatment of bone and joint diseases, but the underlying mechanism has not been fully described. This study aimed to examine the therapeutic effect and potential mechanism of ZG on postmenopausal osteoporosis. The ovariectomized (OVX) mice were treated with normal saline or ZG for 4\u00a0weeks after ovariectomy following a series of analyses. The bone mass density (BMD) and trabecular parameters were examined by micro-CT. Bone remodeling was evaluated by the bone histomorphometry analysis and ELISA assay of bone turnover biomarkers in serum. The possible drug\u2013disease common targets were analyzed by network pharmacology. To predict the potential biological processes and related pathways, GO\/KEGG enrichment analysis was performed. The effects of ZG on the differentiation phenotype of osteoclasts and osteoblasts and the predicted pathway were verified <jats:italic>in vitro<\/jats:italic>. The results showed that ZG significantly improved the bone mass and micro-trabecular architecture in OVX mice compared with untreated OVX mice. ZG could promote bone formation and inhibit bone resorption to ameliorate ovariectomy-induced osteoporosis as evidenced by increased number of osteoblast (N.Ob\/Tb.Pm) and decreased number of osteoclast (N.Oc\/Tb.Pm) in treated group compared with untreated OVX mice. After identifying potential drug\u2013disease common targets by network pharmacology, GO enrichment analysis predicted that ZG might affect various biological processes including osteoblastic differentiation and osteoclast differentiation. The KEGG enrichment analysis suggested that PI3K\/Akt and mTOR signaling pathways could be the possible pathways. Furthermore, the experiments <jats:italic>in vitro<\/jats:italic> validated our findings. ZG significantly down-regulated the expression of osteoclast differentiation markers, reduced osteoclastic resorption, and inhibited the phosphorylation of PI3K\/Akt, while ZG obviously up-regulated the expression of osteogenic biomarkers, promoted the formation of calcium nodules, and hampered the phosphorylation of 70S6K1\/mTOR, which can be reversed by the corresponding pathway activator. Thus, our study suggested that ZG could inhibit the PI3K\/Akt signaling pathway to reduce osteoclastic bone resorption as well as hamper the mTORC1\/S6K1 signaling pathway to promote osteoblastic bone formation.<\/jats:p>","DOI":"10.3389\/fphar.2021.727808","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T09:22:37Z","timestamp":1633080157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation"],"prefix":"10.3389","volume":"12","author":[{"given":"Wang","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/164_2019_329","article-title":"New Targets and Emergent Therapies for Osteoporosis","volume":"262","author":"Brommage","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1159\/000492554","article-title":"Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption via Inhibition of AKT and AP-1 Pathways In Vitro","volume":"48","author":"Chai","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"pe1","DOI":"10.1126\/stke.2001.66.pe1","article-title":"PDK2: A Complex Tail in One Akt","volume":"2001","author":"Chan","year":"2001","journal-title":"Sci. STKE"},{"key":"B4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcp.2017.06.123","article-title":"Major Achievements of Evidence-Based Traditional Chinese Medicine in Treating Major Diseases","volume":"139","author":"Chao","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.7150\/thno.30206","article-title":"Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/cdd.2017.110","article-title":"MTOR\/Raptor Signaling Is Critical for Skeletogenesis in Mice through the Regulation of Runx2 Expression","volume":"24","author":"Dai","year":"2017","journal-title":"Cell Death Differ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal Osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41574-020-00426-5","article-title":"Emerging Insights into the Comparative Effectiveness of Anabolic Therapies for Osteoporosis","volume":"17","author":"Estell","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41574-019-0220-8","article-title":"Fracture Prediction, Imaging and Screening in Osteoporosis","volume":"15","author":"Fuggle","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6666836","article-title":"Icariin Promotes the Osteogenesis of Bone Marrow Mesenchymal Stem Cells through Regulating Sclerostin and Activating the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"2021","author":"Gao","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.15586\/jptcp.v26.i4.646","article-title":"Pharmacological Management of Osteoporosis in Postmenopausal Women: The Current State of the Art","volume":"26","author":"Gatti","year":"2019","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.cell.2021.03.060","article-title":"mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events","volume":"184","author":"Holz","year":"2021","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT Network at the Interface of Oncogenic Signalling and Cancer Metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1005426","DOI":"10.1371\/journal.pgen.1005426","article-title":"mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway","volume":"11","author":"Huang","year":"2015","journal-title":"Plos Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pharmthera.2016.01.015","article-title":"Preclinical Studies and Clinical Evaluation of Compounds from the Genus Epimedium for Osteoporosis and Bone Health","volume":"162","author":"Indran","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis Treatment: Recent Developments and Ongoing Challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00018-018-2981-y","article-title":"Coupling Factors Involved in Preserving Bone Balance","volume":"76","author":"Kim","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the Nexus of Nutrition, Growth, Ageing and Disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cel Biol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005467.pub2","article-title":"Chinese Herbal Medicines for Treating Osteoporosis","volume":"2014","author":"Liu","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B20","first-page":"411","article-title":"Zhuangguguanjie Formulation Protects Articular Cartilage from Degeneration in Joint Instability-Induced Murine Knee Osteoarthritis","volume":"10","author":"Lu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt Induces Osteoclast Differentiation through Regulating the GSK3\u03b2\/NFATc1 Signaling Cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biotechadv.2011.08.004","article-title":"Systems Biology of the Metabolic Network Regulated by the Akt Pathway","volume":"30","author":"Mosca","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574lsf","article-title":"Dose Translation from Animal to Human Studies Revisited","volume":"22","author":"Reagan\u2010Shaw","year":"2008","journal-title":"FASEB j."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic Approaches to Bone Diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1875-5364(21)60001-8","article-title":"TCM Network Pharmacology: A New Trend towards Combining Computational, Experimental and Clinical Approaches","volume":"19","author":"Wang","year":"2021","journal-title":"Chin. J. Nat. Medicines"},{"key":"B26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and Pathophysiological Bone Turnover - Role of the Immune System","volume":"12","author":"Weitzmann","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbrc.2018.11.201","article-title":"Icariin Inhibits RANKL-Induced Osteoclastogenesis via Modulation of the NF-\u03baB and MAPK Signaling Pathways","volume":"508","author":"Xu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41574-019-0282-7","article-title":"A Road Map for Understanding Molecular and Genetic Determinants of Osteoporosis","volume":"16","author":"Yang","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","article-title":"Traditional Chinese Medicine Formulas for the Treatment of Osteoporosis: Implication for Antiosteoporotic Drug Discovery","volume":"189","author":"Zhang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"891","DOI":"10.4103\/0366-6999.179789","article-title":"Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-Center, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Trial","volume":"129","author":"Zhang","year":"","journal-title":"Chin. Med. J. (Engl)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1002\/jcp.29205","article-title":"Antiosteoclastic Bone Resorption Activity of Osteoprotegerin via Enhanced AKT\/mTOR\/ULK1-mediated Autophagic Pathway","volume":"235","author":"Zhao","year":"2020","journal-title":"J. Cel. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"101419","DOI":"10.1016\/j.ctcp.2021.101419","article-title":"Efficacy of Chinese Patent Medicine for Primary Osteoporosis: A Network Meta-Analysis","volume":"44","author":"Zhao","year":"2021","journal-title":"Complement. Ther. Clin. Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1646905","article-title":"Applications of Network Pharmacology in Traditional Chinese Medicine Research","volume":"2020","author":"Zhou","year":"2020","journal-title":"Evidence-Based Complement. Altern. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00198-009-1010-2","article-title":"A Survey of Bone mineral Density of Healthy Han Adults in China","volume":"21","author":"Zhu","year":"2010","journal-title":"Osteoporos. Int."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.727808\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T09:22:41Z","timestamp":1633080161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.727808\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":34,"alternative-id":["10.3389\/fphar.2021.727808"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.727808","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"727808"}}